Cargando…

Efficacy of an alcohol‐based surface disinfectant formulation against human norovirus

AIM: To evaluate the anti‐noroviral efficacy of PURELL® surface sanitizer and disinfectant spray (PSS, an alcohol‐based formulation) using human norovirus GII.4 Sydney [hNoV, by RT‐qPCR and human intestinal enteroid (HIE) infectivity assay] and its cultivable surrogate, Tulane virus (TuV, infectivit...

Descripción completa

Detalles Bibliográficos
Autores principales: Escudero‐Abarca, Blanca I., Goulter, Rebecca M., Bradshaw, Justin, Faircloth, Jeremy, Leslie, Rachel A., Manuel, Clyde S., Arbogast, James W., Jaykus, Lee‐Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306916/
https://www.ncbi.nlm.nih.gov/pubmed/35137492
http://dx.doi.org/10.1111/jam.15479
_version_ 1784752649252372480
author Escudero‐Abarca, Blanca I.
Goulter, Rebecca M.
Bradshaw, Justin
Faircloth, Jeremy
Leslie, Rachel A.
Manuel, Clyde S.
Arbogast, James W.
Jaykus, Lee‐Ann
author_facet Escudero‐Abarca, Blanca I.
Goulter, Rebecca M.
Bradshaw, Justin
Faircloth, Jeremy
Leslie, Rachel A.
Manuel, Clyde S.
Arbogast, James W.
Jaykus, Lee‐Ann
author_sort Escudero‐Abarca, Blanca I.
collection PubMed
description AIM: To evaluate the anti‐noroviral efficacy of PURELL® surface sanitizer and disinfectant spray (PSS, an alcohol‐based formulation) using human norovirus GII.4 Sydney [hNoV, by RT‐qPCR and human intestinal enteroid (HIE) infectivity assay] and its cultivable surrogate, Tulane virus (TuV, infectivity assay), compared to sodium hypochlorite (NaOCl) solutions. METHODS AND RESULTS: PSS efficacy was evaluated in suspension and on surfaces [stainless steel (SS)] using ASTM methods. Results were expressed as log(10) reduction (LR) of genome equivalent copy number (GEC, for hNoV, assayed by RT‐qPCR) and plaque forming units (PFU, for TuV, per infectivity assay). In suspension, PSS achieved a 2.9 ± 0.04 LR hNoV GEC irrespective of contact time (30 or 60 s) and soil load (2.5% or 5%). Under all treatment conditions, infectious TuV could not be recovered following exposure to PSS, corresponding to the assay limit of detection (3.1–5.2 log(10) PFU). Infectious hNoV could not be detected in the HIE model after exposure to PSS. On SS and 2.5% soil, PSS produced a 3.1 ± 0.1 LR hNoV GEC, comparable to 500 ppm NaOCl for 60 s. With 5.0% soil, PSS produced a 2.5 ± 0.2 LR hNoV GEC, which was similar to 1000–5000 ppm NaOCl for 60 s. CONCLUSIONS: PSS showed high anti‐hNoV efficacy by RT‐qPCR and in in vitro (TuV) and ex vivo (HIE) infectivity assays and performed similar to 1000–5000 ppm NaOCl for a 60‐s contact time on SS with added soil. SIGNIFICANCE AND IMPACT OF STUDY: hNoV remains a significant cause of morbidity globally, partly due to its resistance to numerous surface disinfectants. RT‐qPCR results from this study indicate PSS efficacy against hNoV is comparable to NaOCl efficacy. Infectivity assays leveraging TuV and the HIE model for hNoV support and confirm loss of virus infectivity. Collectively, these results indicate the product’s ability to inactivate hNoV quickly, which could be beneficial in settings having elevated risk for hNoV transmission.
format Online
Article
Text
id pubmed-9306916
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93069162022-07-28 Efficacy of an alcohol‐based surface disinfectant formulation against human norovirus Escudero‐Abarca, Blanca I. Goulter, Rebecca M. Bradshaw, Justin Faircloth, Jeremy Leslie, Rachel A. Manuel, Clyde S. Arbogast, James W. Jaykus, Lee‐Ann J Appl Microbiol Original Articles AIM: To evaluate the anti‐noroviral efficacy of PURELL® surface sanitizer and disinfectant spray (PSS, an alcohol‐based formulation) using human norovirus GII.4 Sydney [hNoV, by RT‐qPCR and human intestinal enteroid (HIE) infectivity assay] and its cultivable surrogate, Tulane virus (TuV, infectivity assay), compared to sodium hypochlorite (NaOCl) solutions. METHODS AND RESULTS: PSS efficacy was evaluated in suspension and on surfaces [stainless steel (SS)] using ASTM methods. Results were expressed as log(10) reduction (LR) of genome equivalent copy number (GEC, for hNoV, assayed by RT‐qPCR) and plaque forming units (PFU, for TuV, per infectivity assay). In suspension, PSS achieved a 2.9 ± 0.04 LR hNoV GEC irrespective of contact time (30 or 60 s) and soil load (2.5% or 5%). Under all treatment conditions, infectious TuV could not be recovered following exposure to PSS, corresponding to the assay limit of detection (3.1–5.2 log(10) PFU). Infectious hNoV could not be detected in the HIE model after exposure to PSS. On SS and 2.5% soil, PSS produced a 3.1 ± 0.1 LR hNoV GEC, comparable to 500 ppm NaOCl for 60 s. With 5.0% soil, PSS produced a 2.5 ± 0.2 LR hNoV GEC, which was similar to 1000–5000 ppm NaOCl for 60 s. CONCLUSIONS: PSS showed high anti‐hNoV efficacy by RT‐qPCR and in in vitro (TuV) and ex vivo (HIE) infectivity assays and performed similar to 1000–5000 ppm NaOCl for a 60‐s contact time on SS with added soil. SIGNIFICANCE AND IMPACT OF STUDY: hNoV remains a significant cause of morbidity globally, partly due to its resistance to numerous surface disinfectants. RT‐qPCR results from this study indicate PSS efficacy against hNoV is comparable to NaOCl efficacy. Infectivity assays leveraging TuV and the HIE model for hNoV support and confirm loss of virus infectivity. Collectively, these results indicate the product’s ability to inactivate hNoV quickly, which could be beneficial in settings having elevated risk for hNoV transmission. John Wiley and Sons Inc. 2022-02-19 2022-05 /pmc/articles/PMC9306916/ /pubmed/35137492 http://dx.doi.org/10.1111/jam.15479 Text en © 2022 The Authors. Journal of Applied Microbiology published by John Wiley & Sons Ltd on behalf of Society for Applied Microbiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Escudero‐Abarca, Blanca I.
Goulter, Rebecca M.
Bradshaw, Justin
Faircloth, Jeremy
Leslie, Rachel A.
Manuel, Clyde S.
Arbogast, James W.
Jaykus, Lee‐Ann
Efficacy of an alcohol‐based surface disinfectant formulation against human norovirus
title Efficacy of an alcohol‐based surface disinfectant formulation against human norovirus
title_full Efficacy of an alcohol‐based surface disinfectant formulation against human norovirus
title_fullStr Efficacy of an alcohol‐based surface disinfectant formulation against human norovirus
title_full_unstemmed Efficacy of an alcohol‐based surface disinfectant formulation against human norovirus
title_short Efficacy of an alcohol‐based surface disinfectant formulation against human norovirus
title_sort efficacy of an alcohol‐based surface disinfectant formulation against human norovirus
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306916/
https://www.ncbi.nlm.nih.gov/pubmed/35137492
http://dx.doi.org/10.1111/jam.15479
work_keys_str_mv AT escuderoabarcablancai efficacyofanalcoholbasedsurfacedisinfectantformulationagainsthumannorovirus
AT goulterrebeccam efficacyofanalcoholbasedsurfacedisinfectantformulationagainsthumannorovirus
AT bradshawjustin efficacyofanalcoholbasedsurfacedisinfectantformulationagainsthumannorovirus
AT fairclothjeremy efficacyofanalcoholbasedsurfacedisinfectantformulationagainsthumannorovirus
AT leslierachela efficacyofanalcoholbasedsurfacedisinfectantformulationagainsthumannorovirus
AT manuelclydes efficacyofanalcoholbasedsurfacedisinfectantformulationagainsthumannorovirus
AT arbogastjamesw efficacyofanalcoholbasedsurfacedisinfectantformulationagainsthumannorovirus
AT jaykusleeann efficacyofanalcoholbasedsurfacedisinfectantformulationagainsthumannorovirus